Charanjit S Rihal

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Principles of percutaneous paravalvular leak closure
    Charanjit S Rihal
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    JACC Cardiovasc Interv 5:121-30. 2012
  2. ncbi Clinical and economic outcomes after introduction of drug-eluting stents
    Charanjit S Rihal
    Division of Cardiovascular Diseases, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Manag Care 16:580-7. 2010
  3. ncbi Economic and clinical outcomes of a physician-led continuous quality improvement intervention in the delivery of percutaneous coronary intervention
    Charanjit S Rihal
    Cardiac Catheterization Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Am J Manag Care 12:445-52. 2006
  4. ncbi Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations
    Charanjit S Rihal
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, Minn 55905, USA
    Circulation 108:2439-45. 2003
  5. ncbi Safety and efficacy of drug-eluting stent for ST-segment elevation myocardial infarction in an unselected consecutive cohort
    Pieter J Vlaar
    Division of Cardiovascular Disease and Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Catheter Cardiovasc Interv 71:764-9. 2008
  6. ncbi Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic
    Abhiram Prasad
    Division of Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 49:1611-8. 2007
  7. ncbi Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005
    Brendan J Doyle
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    JACC Cardiovasc Interv 1:202-9. 2008
  8. ncbi Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans
    Ahmad A Elesber
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Am Heart J 153:1081-7. 2007
  9. ncbi Lack of correlation between noninvasive stress tests and invasive coronary vasomotor dysfunction in patients with nonobstructive coronary artery disease
    Andrew Cassar
    Department of Internal Medicine, Mayo College of Medicine, Rochester, MN 55905, USA
    Circ Cardiovasc Interv 2:237-44. 2009
  10. ncbi Nonrevascularizable coronary artery disease following coronary artery bypass graft surgery: a population-based study in Olmsted County, Minnesota
    Thomas J Kiernan
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    Coron Artery Dis 20:106-11. 2009

Detail Information

Publications113 found, 100 shown here

  1. ncbi Principles of percutaneous paravalvular leak closure
    Charanjit S Rihal
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    JACC Cardiovasc Interv 5:121-30. 2012
    ..With careful anatomical assessment, procedural planning, and procedural execution, successful closure rates of 90% or more should be attainable with a low risk of device impingement on the prosthetic valve or embolization...
  2. ncbi Clinical and economic outcomes after introduction of drug-eluting stents
    Charanjit S Rihal
    Division of Cardiovascular Diseases, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Manag Care 16:580-7. 2010
    ..In clinical trials, drug-eluting stents (DES) improve clinical outcomes but are more expensive than bare-metal stents (BMS)...
  3. ncbi Economic and clinical outcomes of a physician-led continuous quality improvement intervention in the delivery of percutaneous coronary intervention
    Charanjit S Rihal
    Cardiac Catheterization Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Am J Manag Care 12:445-52. 2006
    ..To compare clinical and economic outcomes associated with percutaneous coronary intervention (PCI) in cohorts before and after continuous quality improvement (CQI) was instituted...
  4. ncbi Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations
    Charanjit S Rihal
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, Minn 55905, USA
    Circulation 108:2439-45. 2003
  5. ncbi Safety and efficacy of drug-eluting stent for ST-segment elevation myocardial infarction in an unselected consecutive cohort
    Pieter J Vlaar
    Division of Cardiovascular Disease and Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Catheter Cardiovasc Interv 71:764-9. 2008
    ..The objective of this study is to investigate the clinical outcome of a large cohort of patients with ST-segment elevation myocardial infarction (STEMI) treated with drug-eluting stents (DES) compared to bare metal stents (BMS)...
  6. ncbi Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic
    Abhiram Prasad
    Division of Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 49:1611-8. 2007
    ....
  7. ncbi Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005
    Brendan J Doyle
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    JACC Cardiovasc Interv 1:202-9. 2008
    ....
  8. ncbi Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans
    Ahmad A Elesber
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Am Heart J 153:1081-7. 2007
    ..The objective of the this study was to determine if CED and CAD factors are associated with diastolic dysfunction before the development of occlusive CAD or clinical heart failure...
  9. ncbi Lack of correlation between noninvasive stress tests and invasive coronary vasomotor dysfunction in patients with nonobstructive coronary artery disease
    Andrew Cassar
    Department of Internal Medicine, Mayo College of Medicine, Rochester, MN 55905, USA
    Circ Cardiovasc Interv 2:237-44. 2009
    ..The ability of noninvasive stress tests to predict coronary vasomotor dysfunction in patients with nonobstructive coronary artery disease is unknown...
  10. ncbi Nonrevascularizable coronary artery disease following coronary artery bypass graft surgery: a population-based study in Olmsted County, Minnesota
    Thomas J Kiernan
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    Coron Artery Dis 20:106-11. 2009
    ..To further the understanding of this patient cohort, we performed a population-based study of post-coronary bypass patients who developed recurrent angina...
  11. ncbi Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention
    Charanjit S Rihal
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Circulation 105:2259-64. 2002
    ..0 mg/dL are at higher risk than nondiabetic patients, whereas all patients with a serum Cr >2.0 are at high risk for ARF. ARF was highly correlated with death during the index hospitalization and after dismissal...
  12. ncbi A longitudinal analysis of outcomes associated with abciximab and eptifibatide in a consecutive series of 3074 percutaneous coronary interventions
    Kirsten H Long
    Department of Health Sciences Research, Division of Health Care Policy and Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Value Health 11:462-9. 2008
    ..We studied the clinical and length of stay (LOS) outcomes of patients undergoing PCI who received either abciximab or eptifibatide...
  13. ncbi Elective percutaneous coronary intervention without on-site cardiac surgery: clinical and economic implications
    Kirsten Hall Long
    Department of Health Sciences Research, Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota 55905, USA
    Med Care 44:406-13. 2006
    ....
  14. ncbi Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score
    Ronen Rubinshtein
    Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic, MB 4 523, 200 First Street SW, Rochester, MN 55905, USA
    Eur Heart J 31:936-42. 2010
    ..The study aim was to evaluate the relation between the Framingham risk score (FRS) and the presence of coronary risk factors to coronary microcirculatory vasodilator function in patients with early coronary atherosclerosis...
  15. ncbi The effect of drug eluting stents on cardiovascular events in patients with intermediate lesions and borderline fractional flow reserve
    Shahar Lavi
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Catheter Cardiovasc Interv 70:525-31. 2007
    ..To assess the role of fractional flow reserve (FFR) in guiding therapy in the drug eluting stent (DES) era...
  16. ncbi Trends, predictors, and outcomes of cerebrovascular events related to percutaneous coronary intervention: a 16-year single-center experience
    Scott J Hoffman
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    JACC Cardiovasc Interv 4:415-22. 2011
    ..We sought to determine trends, predictors, in-hospital and long-term outcomes of cerebrovascular events (CVE) related to percutaneous coronary intervention (PCI) over a 16-year period...
  17. ncbi Clinical features, management, and prognosis of spontaneous coronary artery dissection
    Marysia S Tweet
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Circulation 126:579-88. 2012
    ..Spontaneous coronary artery dissection (SCAD) is an acute coronary event of uncertain origin. Clinical features and prognosis remain insufficiently characterized...
  18. ncbi Factors associated with 30-day readmission rates after percutaneous coronary intervention
    Farhan J Khawaja
    Mayo Clinic, Rochester, MN 55905, USA
    Arch Intern Med 172:112-7. 2012
    ..However, little is known regarding the factors associated with 30-day readmission after PCI...
  19. ncbi Association of body mass index with outcome after percutaneous coronary intervention
    Brian D Powell
    Division of Cardiovascular Diseases and Internal Medicine and Section of Biostatistics, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Cardiol 91:472-6. 2003
  20. ncbi Myocardial perfusion in apical ballooning syndrome correlate of myocardial injury
    Ahmad Elesber
    Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    Am Heart J 152:469.e9-13. 2006
    ..Microvascular dysfunction likely play a pivotal role in the pathogenesis of myocardial stunning in ABS...
  21. ncbi Temporal trends and improved outcomes of percutaneous coronary revascularization in nonagenarians
    Aaron M From
    Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, Minnesota, USA
    JACC Cardiovasc Interv 1:692-8. 2008
    ..The aim of this study was to describe the clinical characteristics and the outcomes of patients 90 years of age or older who were treated with percutaneous coronary intervention (PCI)...
  22. ncbi Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions
    Patricia J M Best
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA
    Am Heart J 146:345-50. 2003
    ..Although abciximab increases the risk of bleeding in all patients, the increase in relative risk is not significantly greater in patients with CRI. Thus, abciximab may be given safely in patients with CRI who are undergoing PCI...
  23. ncbi Eptifibatide vs abciximab as adjunctive therapy during primary percutaneous coronary intervention for acute myocardial infarction
    Ganesh Raveendran
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 82:196-202. 2007
    ..To compare outcomes among patients receiving eptifibatide or abciximab during primary percutaneous coronary intervention (PCI) for acute myocardial infarction (MI) with ST elevation or new left bundle branch block...
  24. ncbi Outcomes of a system-wide protocol for elective and nonelective coronary angioplasty at sites without on-site surgery: the Mayo Clinic experience
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 84:501-8. 2009
    ..To compare outcomes of percutaneous coronary interventions (PCIs) at 2 community hospitals without on-site surgery (Franciscan Skemp Healthcare and Immanuel St. Joseph's Hospital) with a center with on-site surgery (Saint Marys Hospital)...
  25. ncbi Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease
    Shahar Lavi
    Division of Cardiovascular Diseases, Mayo College of Medicine, Rochester, MN 55905, USA
    Circulation 115:2621-7. 2007
    ..The present study was designed to test the hypothesis that smoking is associated with epicardial coronary endothelial dysfunction and inflammation...
  26. ncbi The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans
    Shahar Lavi
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn 55905, USA
    Hypertension 51:127-33. 2008
    ..This study supports the hypothesis that local oxidative stress has a role in reduction of NO bioavailability in humans with coronary endothelial dysfunction...
  27. ncbi Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression
    Eugenia Raichlin
    Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 53:1279-86. 2009
    ....
  28. ncbi Emergency coronary artery bypass surgery for percutaneous coronary interventions: changes in the incidence, clinical characteristics, and indications from 1979 to 2003
    Eric H Yang
    Division of Cardiovascular Disease and Internal Medicine, Mayo College of Medicine, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 46:2004-9. 2005
    ..However, the in-hospital mortality rate for those requiring emergency CABG remains high and unchanged...
  29. ncbi Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy
    Paul Sorajja
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
    Circulation 126:2374-80. 2012
    ..This study examined the survival of patients after septal ablation performed in a tertiary HCM referral center...
  30. ncbi Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems
    Yoshiki Matsuo
    The Division of Cardiovascular Disease, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Atherosclerosis 223:365-71. 2012
    ..The purpose of this study was to compare the plaque morphology and arterial remodeling between coronary and peripheral arteries using gray-scale and radiofrequency intravascular ultrasound (IVUS) at clinical presentation...
  31. ncbi Outcomes after coronary stent implantation in patients with metal allergy
    Santiago Romero-Brufau
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Circ Cardiovasc Interv 5:220-6. 2012
    ..Clinical outcomes after stent placement in patients with a history of metal allergy remain incompletely understood. We performed a single-center retrospective study to evaluate such outcomes...
  32. ncbi Comparison of frail patients versus nonfrail patients ≥65 years of age undergoing percutaneous coronary intervention
    S Michael Gharacholou
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
    Am J Cardiol 109:1569-75. 2012
    ..001 for each health status domain). In conclusion, 1/5 of older patients are frail at the time of PCI and have greater comorbid burden, angiographic disease severity, and poorer health status than nonfrail adults...
  33. ncbi Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy
    Uma S Valeti
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
    J Am Coll Cardiol 49:350-7. 2007
    ..This study sought to describe the acute morphologic differences that result from septal myectomy and alcohol septal ablation using cardiac magnetic resonance (CMR) imaging...
  34. ncbi Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization
    Mandeep Singh
    Divisions of Cardiovascular Diseases and Department of Health Sciences Research, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, and the Mayo Clinic and Mid America Heart Institute, Rochester, MN 55905, USA
    Circ Cardiovasc Qual Outcomes 4:496-502. 2011
    ..Their inclusion improves the discriminatory ability of the Mayo Clinic risk score derived from the routine cardiovascular risk factors...
  35. ncbi Myocardial ischaemia in patients with coronary endothelial dysfunction: insights from body surface ECG mapping and implications for invasive evaluation of chronic chest pain
    Matthew R Summers
    The Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Eur Heart J 32:2758-65. 2011
    ..The aim of this study was to correlate the magnitude of coronary ED with the presence and extent of inducible myocardial ischaemia using body surface electrocardiogram (ECG) mapping in symptomatic patients...
  36. ncbi Systems of care to improve timeliness of reperfusion therapy for ST-segment elevation myocardial infarction during off hours: the Mayo Clinic STEMI protocol
    David R Holmes
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    JACC Cardiovasc Interv 1:88-96. 2008
    ..We implemented the Mayo Clinic ST-segment elevation myocardial infarction (STEMI) protocol and evaluated the timeliness of reperfusion therapy during off hours versus regular hours...
  37. ncbi Comparison of drug-eluting and bare-metal stents for stable coronary artery disease
    Brian Horst
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    JACC Cardiovasc Interv 2:321-8. 2009
    ..The current study was designed to determine whether drug-eluting stents (DES) are superior to bare-metal stents (BMS) in patients with stable angina...
  38. ncbi Thirty-year trends in outcomes of percutaneous coronary interventions in diabetic patients
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 88:22-30. 2013
    ..To characterize in-hospital and long-term outcomes after percutaneous coronary interventions (PCIs) in patients with diabetes mellitus (DM)...
  39. ncbi The long-term effect of coronary stenting on epicardial and microvascular endothelial function
    Seong Hoon Lim
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Circ Cardiovasc Interv 5:523-9. 2012
    ..However, less is known about their impact on coronary microvascular function and their long-term effects on the vasculature...
  40. ncbi Complications associated with left ventricular puncture
    Sridevi R Pitta
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Catheter Cardiovasc Interv 76:993-7. 2010
    ..To report complications in a consecutive series of patients undergoing percutaneous left ventricular apical puncture (LVAP) and sheath placement for diagnostic or interventional procedures...
  41. ncbi The association between renal atherosclerotic plaque characteristics and renal function before and after renal artery intervention
    Takuro Takumi
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 86:1165-72. 2011
    ..To evaluate the effect of plaque composition on renal function after renal artery intervention (RAI)...
  42. ncbi Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy
    Paul Sorajja
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Circulation 118:131-9. 2008
    ..This study examines the outcome of alcohol septal ablation performed at a tertiary hypertrophic cardiomyopathy referral center...
  43. ncbi Acute myocardial infarction due to left circumflex artery occlusion and significance of ST-segment elevation
    Aaron M From
    Division of Cardiovascular Diseases, Department of Internal Medicine, Rochester, Minnesota, USA
    Am J Cardiol 106:1081-5. 2010
    ..The study results suggest that detection of these patients has been suboptimal, highlighting the need to improve the diagnostic approach toward the detection of an acutely occluded LC artery...
  44. ncbi Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 40:387-93. 2002
    ..782 (standard deviation, 0.018). CONCLUSIONS: Eight variables were combined into a convenient bedside risk scoring system that estimates the risk of complications after PCIs...
  45. ncbi Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans
    Shahar Lavi
    Division of Cardiovascular Diseases, Mayo Clinic, Mary Brigh 4 523, First ST SW, Rochester, MN 55905, USA
    Circulation 115:2715-21. 2007
    ..Inflammation also is associated with coronary atherosclerosis. We tested the hypothesis that local coronary production of Lp-PLA2 is enhanced in patients with early coronary atherosclerosis and associated with local endothelial function...
  46. ncbi Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients
    Abhiram Prasad
    Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn, USA
    Circ Cardiovasc Interv 1:10-9. 2008
    ..The aim of this study was to evaluate the relative impact of preprocedural and postprocedural cardiac troponin T (cTnT) levels on survival rate after PCI...
  47. ncbi Electrocardiography cannot reliably differentiate transient left ventricular apical ballooning syndrome from anterior ST-segment elevation myocardial infarction
    Kevin A Bybee
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Electrocardiol 40:38.e1-6. 2007
    ..We tested the hypothesis that the ECG on presentation could reliably differentiate these syndromes...
  48. ncbi Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease
    Brian D Powell
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
    Am J Cardiol 98:116-20. 2006
    ..In conclusion, ventricular remodeling, LV diastolic dysfunction, and elevated filling pressures may contribute to the prevalence of heart failure in obese patients...
  49. ncbi Percutaneous revascularization for stable coronary artery disease temporal trends and impact of drug-eluting stents
    Anthony A Hilliard
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    JACC Cardiovasc Interv 3:172-9. 2010
    ..We sought to determine the characteristics, outcomes, and temporal trends among patients undergoing percutaneous coronary intervention (PCI) for stable coronary artery disease (CAD) from a single-center registry...
  50. ncbi Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization
    Abhiram Prasad
    Division of Cardiovascular Diseases and Department of Internal Medicine, Rochester, Minn, USA
    Am Heart J 147:1066-70. 2004
    ..In this population, 56% of patients survived to be discharged from the hospital, and of the hospital survivors, 75% were alive at 1 year...
  51. ncbi Incidence, retrieval methods, and outcomes of stent loss during percutaneous coronary intervention: a large single-center experience
    Emmanouil S Brilakis
    Division of Cardiovascular Diseases, University of Texas Southwestern Medical Center, Dallas, Texas 75216, USA
    Catheter Cardiovasc Interv 66:333-40. 2005
    ..Stent deployment or crushing may be a good alternative to retrieval...
  52. ncbi The association of serum uric acid levels with outcomes following percutaneous coronary intervention
    Daniel B Spoon
    Division of Cardiovascular Disease and Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Interv Cardiol 23:277-83. 2010
    ..Our goal was to assess the association of serum uric acid levels and the outcomes of patients who have undergone percutaneous coronary intervention (PCI)...
  53. ncbi In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction
    Lin Y Chen
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
    Am J Cardiol 95:349-54. 2005
    ....
  54. ncbi Prediction of complications following nonemergency percutaneous coronary interventions
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Cardiol 96:907-12. 2005
    ....
  55. ncbi Features of cardiac allograft coronary endothelial dysfunction
    Eugenia Raichlin
    Mayo Clinic, Rochester, Minnesota, USA
    Am J Cardiol 103:1154-8. 2009
    ..In conclusion, cardiac allograft epicardial coronary endothelial function was abnormal and may be related to an impaired endogenous NO synthetase pathway and reduced endothelial nitric oxide production in transplant recipients...
  56. ncbi Diagnosis and treatment of viral myocarditis
    Jason C Schultz
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 84:1001-9. 2009
    ..Main keywords searched were myocarditis, dilated cardiomyopathy, endomyocardial biopsy, cardiac magnetic resonance imaging, and immunotherapy...
  57. ncbi Drug-eluting stents in octogenarians: early and intermediate outcome
    Pieter J Vlaar
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
    Am Heart J 155:680-6. 2008
    ..Large randomized controlled trials have demonstrated that percutaneous coronary intervention with the routine use of drug-eluting stents is safe and effective. However, octogenarians are usually excluded from these trials...
  58. ncbi Effect of septal ablation on myocardial relaxation and left atrial pressure in hypertrophic cardiomyopathy an invasive hemodynamic study
    Paul Sorajja
    Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    JACC Cardiovasc Interv 1:552-60. 2008
    ..The objective of this study was to examine the effects of septal ablation on diastolic function with the use of invasive hemodynamics...
  59. ncbi Chronic coronary artery disease: diagnosis and management
    Andrew Cassar
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 84:1130-46. 2009
    ....
  60. ncbi Comparison of Mayo Clinic risk score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Rochester, Minnesota, USA
    J Am Coll Cardiol 44:357-61. 2004
    ..We compared American College of Cardiology/American Heart Association (ACC/AHA) lesion classification with the recently proposed Mayo Clinic risk score to predict complications following percutaneous coronary intervention (PCI)...
  61. ncbi Adipose tissue of atrial septum as a marker of coronary artery disease
    Nithima Chaowalit
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First St, Rochester, MN 55905, USA
    Chest 132:817-22. 2007
    ..Adipose tissue is the main determinant of atrial septum thickness. The association between atrial septum thickness and coronary artery disease (CAD) has never been studied...
  62. ncbi Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 51:2313-20. 2008
    ..Our aim was to examine whether gender-based differences in mortality after percutaneous coronary interventions (PCIs) have changed in the past 25 years...
  63. ncbi Coronary endothelial dysfunction is associated with a reduction in coronary artery compliance and an increase in wall shear stress
    Takuro Takumi
    Division of Cardiovascular Disease, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
    Heart 96:773-8. 2010
    ..The purpose of this study was to investigate the association between coronary endothelial dysfunction, coronary artery compliance and wall shear stress in patients with early atherosclerosis...
  64. ncbi Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells
    Mario Gossl
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA
    Eur Heart J 31:2909-14. 2010
    ..The current study was designed to test the hypothesis that early coronary atherosclerosis is associated with the retention of osteogenic EPC within the coronary circulation...
  65. ncbi Clinical determinants of radiation dose in percutaneous coronary interventional procedures: influence of patient size, procedure complexity, and performing physician
    Kenneth A Fetterly
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    JACC Cardiovasc Interv 4:336-43. 2011
    ..The objectives of this work were to establish the primary clinical determinants of patient radiation dose associated with percutaneous coronary interventional (PCI) and to identify opportunities for dose reduction...
  66. ncbi Circadian rhythms in patients with ST-elevation myocardial infarction
    David R Holmes
    Mayo Clinic, Rochester, MN 55905, USA
    Circ Cardiovasc Qual Outcomes 3:382-9. 2010
    ..We evaluated these rhythms in patients with ST-elevation myocardial infarction as a function of the 24-hour circadian cycle...
  67. ncbi A total of 1,007 percutaneous coronary interventions without onsite cardiac surgery: acute and long-term outcomes
    Henry H Ting
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 47:1713-21. 2006
    ....
  68. ncbi Plasma 8-iso-prostaglandin F2alpha, a marker of oxidative stress, is increased in patients with acute myocardial infarction
    Ahmad A Elesber
    The Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Free Radic Res 40:385-91. 2006
    ..Endogenous oxidative stress may contribute to the pathogenesis of atherosclerosis and its complications, namely myocardial infarction...
  69. ncbi Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores
    Mandeep Singh
    Division of Cardiovascular Diseases, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 82:701-8. 2007
    ..To derive risk models for percutaneous coronary intervention (PCI) outcomes from clinical and laboratory variables available before the procedure so they can be used for preprocedure risk stratification...
  70. ncbi Coronary revascularization in the community. A population-based study, 1990 to 2004
    Yariv Gerber
    Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 50:1223-9. 2007
    ..We sought to examine temporal trends in the utilization of coronary revascularization in a geographically defined population...
  71. ncbi Association between the paraoxonase-1 192Q>R allelic variant and coronary endothelial dysfunction in patients with early coronary artery disease
    Shahar Lavi
    Division of Cardiovascular Diseases, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 83:158-64. 2008
    ..To test the hypothesis that allelic variants of the paraoxonase-1 gene are associated with endothelial dysfunction, an early stage of atherosclerosis...
  72. ncbi Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction
    Abhiram Prasad
    The Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    Am Heart J 155:408-17. 2008
    ....
  73. ncbi Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry
    James L Orford
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Am Coll Cardiol 40:1567-72. 2002
    ..CONCLUSIONS: Stent thrombosis is even more rare in the current era than in earlier trials. Number of stents placed was an independent correlate of stent thrombosis. Most patients who suffer stent thrombosis either die or suffer MI...
  74. ncbi Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans
    Eric H Yang
    Division of Cardiovascular Diseases, Mayo College of Medicine, Rochester, MN 55905, USA
    Arterioscler Thromb Vasc Biol 26:106-11. 2006
    ..3 (95% CI, 1.6 to 6.6). CONCLUSIONS: Lp-PLA2 is independently associated with coronary artery endothelial dysfunction and is a strong predictor of endothelial dysfunction in humans...
  75. ncbi Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol
    Henry H Ting
    MBA, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905
    Circulation 116:729-36. 2007
    ..We implemented and evaluated a protocol to optimize the timeliness of reperfusion therapy and to coordinate systems of care for a PCI center and 28 regional hospitals located up to 150 miles away across 3 states...
  76. ncbi Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents
    Jennifer A Rabbitts
    Department of Anesthesiology, Mayo Clinic, 200 First Street Southwest, Rochester, Minnesota 55905, USA
    Anesthesiology 109:596-604. 2008
    ..The American College of Cardiology released a scientific advisory that included a recommendation to delay elective of noncardiac surgery (NCS) for 1 yr after percutaneous coronary intervention (PCI) with a drug-eluting stent (DES)...
  77. ncbi Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction
    Kevin A Bybee
    Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Ann Intern Med 141:858-65. 2004
    ..An episode of emotional or physiologic stress frequently precedes presentation with the syndrome. The in-hospital mortality rate seems to be low, as does the risk for recurrence...
  78. ncbi Utility of isoproterenol to provoke outflow tract gradients in patients with hypertrophic cardiomyopathy
    Ahmad Elesber
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
    Am J Cardiol 101:516-20. 2008
    ..In conclusion, cardiac catheterization with isoproterenol challenge may identify patients with HC who may benefit from septal reduction therapy for whom the initial noninvasive evaluation does not show severe obstruction...
  79. ncbi Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 79:1113-8. 2004
    ..On follow-up, the short-term and long-term outcomes of patients with PAD were worse, with higher mortality, MI, and need for repeated target vessel revascularization...
  80. ncbi Narrative review: reperfusion strategies for ST-segment elevation myocardial infarction
    Henry H Ting
    Cardiac Catheterization Laboratory, Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Ann Intern Med 145:610-7. 2006
    ....
  81. ncbi Relation of preprocedural statin therapy to in-hospital procedural complications following percutaneous coronary interventions in patients with hyperlipidemia
    Mandeep Singh
    The Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Cardiol 98:325-30. 2006
    ..In conclusion, hyperlipidemia per se is not associated with lower in-hospital complications after PCI. The benefit is largely limited to patients on statin treatment...
  82. ncbi Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents
    Brendan Doyle
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Circulation 116:2391-8. 2007
    ..The sequelae of late BMS failures, however, have been poorly characterized...
  83. ncbi Sustaining improvement in door-to-balloon time over 4 years: the Mayo clinic ST-elevation myocardial infarction protocol
    David M Nestler
    Department of Emergency Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA
    Circ Cardiovasc Qual Outcomes 2:508-13. 2009
    ..Systems of care to achieve and sustain this DTB performance over several years have not been previously reported...
  84. ncbi Four-year recurrence rate and prognosis of the apical ballooning syndrome
    Ahmad A Elesber
    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 50:448-52. 2007
    ..This study sought to assess the long-term prognosis of patients with apical ballooning syndrome (ABS)...
  85. ncbi Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST-elevation acute myocardial infarction
    Emmanouil S Brilakis
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Am Heart J 146:811-8. 2003
    ..77) mortality. CONCLUSIONS: The PURSUIT risk score correlates with EF, angiographic severity of coronary artery disease, and short- and long-term mortality of nonselected patients with non-ST-elevation acute myocardial infarction...
  86. ncbi Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome
    Kevin A Bybee
    Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Am J Cardiol 94:343-6. 2004
    ..TIMI frame counts were abnormal in all patients and often abnormal in all 3 major coronary vessels, suggesting that the diffuse impairment of coronary microcirculatory function may play a role in the pathogenesis of the syndrome...
  87. ncbi Rheolytic thrombectomy with Angiojet in thrombus-containing lesions
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Catheter Cardiovasc Interv 56:1-7. 2002
    ..It is effective in both native coronary arteries and vein graft interventions. However, the long-term outcome of patients with vein graft intervention was worse...
  88. ncbi Mitral regurgitation in patients with advanced systolic heart failure
    Jeetendra B Patel
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Card Fail 10:285-91. 2004
    ..CONCLUSION: Among patients with advanced CHF, hemodynamically significant MR is common. The severity of MR did not provide independent prognostic information in this group recognized to have uniformly high mortality...
  89. ncbi Outcomes of cardiopulmonary resuscitation and predictors of survival in patients undergoing coronary angiography including percutaneous coronary interventions
    Juraj Sprung
    Department of Anesthesiology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Anesth Analg 102:217-24. 2006
    ..Patients who received CPR in the cardiac catheterization lab have a remarkably frequent survival to hospital discharge rate. Long-term survival of these patients is only minimally reduced...
  90. ncbi Safety of same-day coronary angiography in patients undergoing elective aortic valve replacement
    Kevin L Greason
    Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA
    Ann Thorac Surg 91:1791-6. 2011
    ..Coronary artery imaging is required for most adult patients undergoing aortic valve replacement (AVR)...
  91. ncbi A critical appraisal of current models of risk stratification for percutaneous coronary interventions
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Am Heart J 149:753-60. 2005
  92. ncbi Cardiopulmonary bypass support for percutaneous coronary interventions: what the anesthesiologist needs to know
    Christopher M Burkle
    Department of Anesthesiology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    J Cardiothorac Vasc Anesth 19:501-4. 2005
  93. ncbi Applicability of distal protection for aortocoronary vein graft interventions in clinical practice
    Verghese Mathew
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Catheter Cardiovasc Interv 63:148-51. 2004
    ..A large number of patients with vein graft disease intended for percutaneous treatment have anatomic exclusions to available distal protection technology...
  94. ncbi Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry
    Mandeep Singh
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota55905, USA
    J Am Coll Cardiol 42:1722-8. 2003
    ..We sought to validate the recently proposed Mayo Clinic risk score model for complications after percutaneous coronary interventions (PCI), using an independent data set...
  95. ncbi The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions
    Patricia J M Best
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    J Am Coll Cardiol 39:1113-9. 2002
    ..Patients with renal insufficiency have more baseline cardiovascular risk factors, but renal insufficiency is associated with an increased risk of death and other adverse cardiovascular events, independent of all other measured variables...
  96. ncbi Evolving challenges in medical device evaluation
    David R Holmes
    Internal Medicine and Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
    Catheter Cardiovasc Interv 72:1-6. 2008
  97. ncbi What physicians should know about coronary stents
    Charanjit S Rihal
    Cardiac Catheterization Laboratory, Mayo Clinic, MN, USA
    Minn Med 91:44-6. 2008
    ....
  98. ncbi Current trends in coronary revascularization
    Shannon M Dunlay
    Véronique L Roger, MD, MPH Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Curr Treat Options Cardiovasc Med 11:61-70. 2009
    ..Accordingly, it is unclear whether the trend in increased use of PCI versus CABG will continue...
  99. ncbi Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Circulation 115:2835-41. 2007
    ..Little is known about the impact of technological and pharmacological advances on long-term outcome after percutaneous coronary intervention in general clinical practice...
  100. ncbi Frequency and predictors of urgent coronary angiography in patients with acute pericarditis
    Adam C Salisbury
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Mayo Clin Proc 84:11-5. 2009
    ..To determine the frequency of urgent coronary angiography in patients with acute pericarditis and to examine clinical characteristics associated with coronary angiography...
  101. ncbi Frailty and its potential relevance to cardiovascular care
    Mandeep Singh
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 83:1146-53. 2008
    ..We also elaborate on reasons to consider frailty in older adults with cardiovascular disease and focus on its early identification, on referral to specialists, and on care after serious cardiac events...